Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Circulating and Urinary Exosomal miRNA as Predictors of Treatment Response in Advanced Kidney Cancer
- Status
- COMPLETED
- Phase
- NA
Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1)
- Status
- COMPLETED
- Phase
- NA
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
- Status
- RECRUITING
- Phase
- PHASE2
Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Cold Ischemia Robot-assisted Partial Nephrectomy
- Status
- RECRUITING
- Phase
- NA
Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- NA
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Status
- RECRUITING
- Phase
- PHASE2
A Novel Haemostatic Agent for Robotic Partial Nephrectomy
- Status
- WITHDRAWN
- Phase
- NA
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Status
- RECRUITING
- Phase
- PHASE3
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Retifanlimab and Ruxolitinib In Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
DESTINY-PANTUMOUR04
- Status
- RECRUITING
- Phase
- N/A
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2